Paragon Biosciences is an investor and incubator company that grows and builds companies in the line of biotechnology. Their focus is to address the needs of a patient, understand the science about the infection, and once that is done, they establish companies that will cater to the unmet needs of the patients. Through this, a successful drug development model is drawn helping in fast approval of significant medicines. Paragon Bioscience says that there are over 6,000 infections that have not found treatment, and that is why they are motivated to reducing the numbers. Jeff Aronin, the chairman and the chief executive officer of Paragon Biosciences, says that they are solving problems that have been rendered unsolvable by many people in the industry. Some of the companies that Paragon Biosciences has developed over time include Castle Creek Pharmaceuticals under the innovative biotechnological companies and they are developing therapies for patients who have rare dermatologic conditions. Harmony Biosciences is the other company that focuses on innovative drugs in meeting the needs of patients with sleep and central nervous system problems. Decade Company is focused on research and development for Alzheimer’s disease. Finally, the Precision BP treat and researches oncology infections.
Jeff Aronin has remained the chief executive officer for Paragon Biosciences since 2010. He founded the company in the year 2009. Alongside Paragon Biosciences, Jeff Aronin serves as a special advisor for Merrick Ventures (https://www.jeffaronin.com/). He as well-founded Lundbeck Inc. in 2000 where he was the chief executive officer. Jeff Aronin has an MBA from DePaul University and a BS from Northern Illinois University.
Jeff has great experience in running most of the global pharmaceutical companies with extensive skills in finance, brand marketing, and business development. He is one of the rich people in wisdom, experience and knowledge in leadership that is necessary for each day management and the movement of a global company. Jeff is not limited to skills since he strongly structures and executes strategies for corporate transactions such as the mergers and acquisitions. This is all the companies need to make a big step in the market world regardless of the sector and specialization. With fruitful efforts, Jeff has been in a position to create transformation in the medical world more so in research and drug development industry.
Check Jeff Aronin’s (LinkedIn) account.